In March 2025, the company introduced new options for the direct-to-buyer presenting of its Wegovy weight loss drug. The company proven a whole new pharmacy, called NovoCare, which might demand buyers $499 each month for use of the drug, below 50 % the cost of the drug by means of other pharmaceutical distribution networks.[fifty three]Comprehendin